Announce your event here
2nd Annual Advances in Immuno-Oncology Congress
2017-05-15 to 2017-05-16
London, UK
Oxford Global is proud to present its 2nd Annual Advances in Immuno-Oncology Congress, on the 15th & 16th of May 2017 in Central London. Over two days our event will bring together 200 senior level attendees from academia, research institutes and pharma companies to discuss the current challenges and future perspectives of Immuno-Oncology. This event provides an ideal platform to participate in formal 1-1 meetings and informal networking drinks with other key industry figures, as well as providing opportunities to exchange ideas with some of the most influential professionals in the field. Please download the agenda here: link

Americas Antibody Congress 2017
2017-05-23 to 2017-05-24
Hilton San Diego Resort and Spa San Diego, CA


This May, researchers from pharma, academia, and biotech will descend on San Diego for two days of networking and content on the challenges to the antibody industry presented by the increased demand for antibody drugs to fight chronic illnesses.

With demand comes innovation. The only antibody event with new data and non-repetitive talks as a requirement to speak, Americas Antibody Congress 2017 will feature sessions on New Data in Antibody Discovery, New Data in Clinical and Commercial Development, and the therapeutic areas of Infectious Diseases and Oncology link

World Immunotherapy Congress USA 2017
Hilton San Diego Resort and Spa San Diego, CA

Discover. Develop. Get to market. For Biotech, Pharma, and Their Partners.

The demand for innovation in immunotherapy can only grow, and new breakthroughs are needed if success rates are to continue. That’s why World Immunotherapy Congress is coming to the USA after an acclaimed launch in Europe. This inaugural event will bring together the brightest and best minds in pharma, biotech, government and academia to build on the development and commercialization of new immunotherapy treatments.

Co-located with the Americas Antibody Congress, Immunotherapy World Congress USA features 2 days of in-depth case studies and discussions around Cell Therapy Strategies, Pre-Clinical Development and Innovative Therapeutic Approaches presented by our partners from biopharma and academia.

2017 Speakers include:

Register now: link

18th Annual Drug Discovery Summit, 12-13 June 2017
2017-06-12 to 2017-06-13
Hotel Palace Berlin, Berlin, Germany

This congress brings together over 250 key opinion leaders and senior industry experts in drug discovery, to discuss the latest innovative discovery strategies in different therapeutic areas as well as the most effective enabling technologies and solutions.

Our event will have over 55 presentations and case studies and panel discussions focused on the key issues in drug discovery and medicinal chemistry.

Including 6 interactive streams

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities.

Co-located with our 5th Annual Discovery Chemistry and Drug Design Congress and our inaugural Microbiome Discovery and Development Congress

Free Webinars available:

Drug Discovery Open Innovation & Outsourcing
Hosted by Patrick Kleyn, Director of Drug Target Innovation, EMD Serono
Register for Free Today:

Phenotypic Screening in Drug Discovery- Novel Tools & Applications
Hosted by Paul Andrews, Director of Operations, National Phenotypic Screening Centre (NPSC), School of Life Sciences, University of Dundee
Register for Free Today:

Disruptive Technologies & Artificial Intelligence in Drug Discovery
Hosted by Chris Gibson, CEO, Recursion Pharmaceuticals
Register for Free Today:

You can also follow us on Twitter @drugdiscovery1 and join the congress conversation on #DDSummit17

For further information on the congress and the webinars, please contact Guillaume Alonso on or call +44 (0) 1865 248 455. link

Digital Pathology Congress: USA
2017-07-10 to 2017-07-11
Palmer House Hilton Hotel, Chicago, IL, USA
As experts position themselves for FDA-approval of primary diagnosis,
the congress will examine the applications and benefits of adopting
digital pathology as well as the business case to be made for it. With
over 200 industry and academic experts expected over the two days, the
congress will provide the opportunity to take home cutting edge
strategies, analysis techniques, case study examples and methods to
allow you to fully understand both the technology and accompanying
informatics and image analysis tools and utilize digital pathology to
its greatest potential. link

4th Annual Drug Discovery USA Congress
2017-10-09 to 2017-10-10
San Diego, USA
Oxford Global’s 4th Annual Drug Discovery USA Congress will take place on 9 – 10 October 2017 in San Diego, USA, bringing together over 250 key opinion leaders in drug discovery. This exciting conference showcases the latest technologies and approaches being utilised across Immuno-therapy, Autoimmune diseases, Neuroscience and Oncology. Further sessions consider the key updates in medicinal and computational chemistry. The two-day congress offers an interactive platform for high level discussions, ensuring valuable networking and interactive sessions.
View Agenda:
4 Interactive Streams:
• Drug Discovery Innovation and Strategies, Enabling Technologies for Immuno-therapy, Autoimmune Diseases, Neuroscience & Oncology
• Successful Phenotypic Drug Discovery: High Content Screening
• Discovery Chemistry: Medicinal and Computational Chemistry
• Discovery Chemistry: Medicinal Chemistry and Novel Approaches to Drug Design link

2nd Annual Biomarkers & Precision Medicine USA Congress
2017-10-09 to 2017-10-10
San Diego, USA

Oxford Global Conferences are proud to present the 2nd Annual Biomarkers & Precision Medicine USA Congress co-located with our 4th Annual Drug Discovery USA Congress, taking place on the 09-10 October 2017 in San Diego, USA.

Over 250 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions.

Over 40 presentations, case studies and panel discussions focused on the key issues in biomarker research, companion diagnostics, personalised medicine and clinical biomarkers.

5 Interactive Streams:

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities. This event is co-located with our 4th Annual Drug Discovery USA Congress.

Free Pre-Congress Webinars

Translational Biomarkers and Companion Diagnostics Development Consortium
22nd June 2017, 9 am. PST, 12 noon EST, 5 pm. BST

Click here to register today, for free.

Scientific and Regulatory Considerations for the Analytical Validation of Assays for the Qualification of Biomarkers

8th August 2017, 9 am. PST, 12 noon EST, 5 pm. BST
Click here to register today, for free.

Can’t make the dates? Still register and a copy of the webinar recording will be sent to you.

For further information, click here: link

9th World Congress of Melanoma and the 14th International Congress of the Society for Melanoma Research
2017-10-18 to 2017-10-21
Brisbane, Australia

The 9th World Congress of Melanoma and the 14th International Congress of the Society for Melanoma Research will be held from 18th to 21st October 2017 in Brisbane, Australia. The joint meeting will bring together the world’s leading melanoma researchers and clinicians to showcase the latest developments in melanoma diagnosis, treatment and research.

This global summit will accelerate scientific and clinical investigations into melanoma, providing an opportunity for delegates from multi-disciplinary fields to meet in a warm climate to exchange knowledge and expertise.

We plan to inspire new partnerships and innovations, and will offer a range of significant benefits to international delegates from across the world, including opportunities to explore new professional horizons that pivot from a uniquely global focus on melanoma and skin cancer control. link

3rd World Congress on Controversies in Breast Cancer (CoBrCa)
2017-10-26 to 2017-10-28
Tokyo, Japan
The 3rd World Congress on Controversies in Breast Cancer (CoBrCa) will take place October 26-28, 2017 in Tokyo, Japan. It will directly address controversial issues in breast cancer faced by clinicians in their daily practice. The congress will focus on key issues in medical oncology, surgery, radiation oncology, reconstruction and pathology. The congress will also provide a forum to effectively debate these unresolved clinical and therapeutic problems. link

2017 NCRI Cancer Conference
2017-11-05 to 2017-11-08
BT Convention Centre, Liverpool, UK

The NCRI Cancer Conference is the largest annual cancer research meeting in the UK, attracting over 1,500 participants from across the spectrum of basic, translational and clinical research. We are committed to share and make available to all attendees the best cancer research from all over the world and encourage cross-pollination. The Conference provides a high profile platform where key stakeholders of cancer research come together to discuss, present and showcase high-quality research. The programme covers six main themes - Diagnosis and therapy, Epidemiology and prevention, Health services research, Information, patients and the public, Survivorship and end of life care and the cancer cell and model systems – which are organised in sessions across 4 days. The Conference programme includes plenty of networking opportunities, allowing participants to make the most of their time in Liverpool.

Key dates:
Abstract submission: 3 April – 4 June
Earlybird registration: 3 April – 30 June
Standard registration: 1 July – 22 October
Late breaking abstract submission: 31 July – 28 August link